ATXS
Price
$9.55
Change
+$0.10 (+1.06%)
Updated
Dec 20, 04:59 PM (EDT)
75 days until earnings call
ORIC
Price
$8.21
Change
+$0.52 (+6.76%)
Updated
Dec 20, 04:59 PM (EDT)
94 days until earnings call
Ad is loading...

ATXS vs ORIC

Header iconATXS vs ORIC Comparison
Open Charts ATXS vs ORICBanner chart's image
Astria Therapeutics
Price$9.55
Change+$0.10 (+1.06%)
Volume$3.51K
CapitalizationN/A
Oric Pharmaceuticals
Price$8.21
Change+$0.52 (+6.76%)
Volume$2.61K
CapitalizationN/A
ATXS vs ORIC Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. ORIC commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and ORIC is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (ATXS: $9.57 vs. ORIC: $8.23)
Brand notoriety: ATXS and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 281% vs. ORIC: 170%
Market capitalization -- ATXS: $540.08M vs. ORIC: $580.77M
ATXS [@Biotechnology] is valued at $540.08M. ORIC’s [@Biotechnology] market capitalization is $580.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, ORIC is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while ORIC’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • ORIC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ATXS and ORIC are a bad buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а +0.53% price change this week, while ORIC (@Biotechnology) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 06, 2025.

ORIC is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($581M) has a higher market cap than ATXS($540M). ATXS YTD gains are higher at: 24.609 vs. ORIC (-10.543). ATXS has higher annual earnings (EBITDA): -100.97M vs. ORIC (-133.69M). ATXS has more cash in the bank: 344M vs. ORIC (272M). ORIC has less debt than ATXS: ORIC (3.12M) vs ATXS (5.64M). ATXS (0) and ORIC (0) have equivalent revenues.
ATXSORICATXS / ORIC
Capitalization540M581M93%
EBITDA-100.97M-133.69M76%
Gain YTD24.609-10.543-233%
P/E RatioN/AN/A-
Revenue00-
Total Cash344M272M126%
Total Debt5.64M3.12M181%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSORIC
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CTOGX15.760.19
+1.22%
Calamos Timpani SMID Growth R6
PLCGX16.830.19
+1.14%
Principal LargeCap Growth I R6
MSCIX12.540.10
+0.80%
Madison Small Cap I
CDWAX10.630.04
+0.39%
American Funds Dvlpg Wld Gr&Inc 529A
PBEAX22.06N/A
N/A
PGIM Jennison Value A

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with IMNM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+1.27%
IMNM - ATXS
43%
Loosely correlated
-0.81%
XENE - ATXS
42%
Loosely correlated
-0.54%
KYMR - ATXS
42%
Loosely correlated
+3.83%
ARVN - ATXS
41%
Loosely correlated
+3.65%
ACLX - ATXS
41%
Loosely correlated
+0.56%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ARVN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+7.02%
ARVN - ORIC
43%
Loosely correlated
+3.65%
KYMR - ORIC
42%
Loosely correlated
+3.83%
IMNM - ORIC
41%
Loosely correlated
-0.81%
OLMA - ORIC
41%
Loosely correlated
+5.53%
DAWN - ORIC
41%
Loosely correlated
+2.57%
More